{"id":"tapinarof-cream-1","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Application site reactions"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Pruritus"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Tapinarof works by activating the aryl hydrocarbon receptor, which leads to the suppression of inflammatory cytokines and the induction of anti-inflammatory cytokines. This results in reduced inflammation and improved symptoms in patients with psoriasis.","oneSentence":"Tapinarof is a topical aryl hydrocarbon receptor agonist that modulates the immune response and reduces inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:52.020Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe plaque psoriasis"}]},"trialDetails":[{"nctId":"NCT07265479","phase":"PHASE3","title":"A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis","status":"RECRUITING","sponsor":"Organon and Co","startDate":"2025-12-29","conditions":"Atopic Dermatitis","enrollment":180},{"nctId":"NCT06561321","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma","status":"RECRUITING","sponsor":"Indiana University","startDate":"2024-10-30","conditions":"Palmoplantar Keratoderma","enrollment":6},{"nctId":"NCT05172726","phase":"PHASE3","title":"Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Organon and Co","startDate":"2021-12-02","conditions":"Plaque Psoriasis","enrollment":58},{"nctId":"NCT05981118","phase":"PHASE2, PHASE3","title":"Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)","status":"ENROLLING_BY_INVITATION","sponsor":"Wake Forest University Health Sciences","startDate":"2024-07-15","conditions":"ICD10 Code L40.9 for Psoriasis","enrollment":40},{"nctId":"NCT06742957","phase":"PHASE3","title":"Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2024-12-17","conditions":"Plaque Type Psorisis","enrollment":560},{"nctId":"NCT05186805","phase":"PHASE2","title":"Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2021-11-15","conditions":"Atopic Dermatitis","enrollment":36},{"nctId":"NCT05014568","phase":"PHASE3","title":"Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2021-09-01","conditions":"Atopic Dermatitis","enrollment":407},{"nctId":"NCT05032859","phase":"PHASE3","title":"Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2021-09-23","conditions":"Atopic Dermatitis","enrollment":406},{"nctId":"NCT05142774","phase":"PHASE3","title":"Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2021-10-28","conditions":"Atopic Dermatitis","enrollment":728},{"nctId":"NCT04053387","phase":"PHASE3","title":"Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2019-08-13","conditions":"Plaque Psoriasis","enrollment":763},{"nctId":"NCT04042103","phase":"PHASE2","title":"Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2019-07-23","conditions":"Plaque Psoriasis","enrollment":21},{"nctId":"NCT05789576","phase":"PHASE4","title":"A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2023-03-13","conditions":"Psoriasis","enrollment":31},{"nctId":"NCT03956355","phase":"PHASE3","title":"Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2019-05-21","conditions":"Plaque Psoriasis","enrollment":510},{"nctId":"NCT05680740","phase":"PHASE4","title":"A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2022-12-27","conditions":"Psoriasis","enrollment":34},{"nctId":"NCT03983980","phase":"PHASE3","title":"Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2019-06-06","conditions":"Plaque Psoriasis","enrollment":515},{"nctId":"NCT06103695","phase":"PHASE4","title":"Vtama in Psoriasis Patients Being Treated With Biologics.","status":"COMPLETED","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2023-02-27","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT05064748","phase":"PHASE4","title":"Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2021-06-01","conditions":"Psoriasis","enrollment":2000},{"nctId":"NCT03202004","phase":"PHASE3","title":"GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2018-01-22","conditions":"Psoriasis","enrollment":""},{"nctId":"NCT03201978","phase":"PHASE1","title":"A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2017-12-14","conditions":"Psoriasis","enrollment":""},{"nctId":"NCT02564055","phase":"PHASE2","title":"A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-12-01","conditions":"Dermatitis, Atopic","enrollment":247},{"nctId":"NCT02564042","phase":"PHASE2","title":"A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-11-23","conditions":"Psoriasis","enrollment":227},{"nctId":"NCT01098721","phase":"PHASE2","title":"A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks","status":"COMPLETED","sponsor":"Welichem Biotech Inc.","startDate":"2010-01","conditions":"Psoriasis","enrollment":61},{"nctId":"NCT01098734","phase":"PHASE2","title":"Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream","status":"COMPLETED","sponsor":"Welichem Biotech Inc.","startDate":"2009-11","conditions":"Dermatitis, Atopic","enrollment":148},{"nctId":"NCT00837551","phase":"PHASE1, PHASE2","title":"Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis","status":"COMPLETED","sponsor":"Welichem Biotech Inc.","startDate":"2008-03","conditions":"Dermatitis, Atopic","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":35,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","companyName":"Teva Pharmaceuticals USA","companyId":"teva-pharmaceuticals-usa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tapinarof is a topical aryl hydrocarbon receptor agonist that modulates the immune response and reduces inflammation. Used for Moderate to severe plaque psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}